World Generic Congress LatAm 2012

The World Generics Congress LatAm is dedicated to challenges and opportunities in generic drug development in Latin America.

Topics

• Market review for generics in Latin America
• Sustainability of healthcare in Latin America
• Regional regulatory policy
• Government responsibility and role in generic drug development
• Biosimilars in Latin America
• Development trends and target indications

Who should Attend

Representatives from: biosimilars developers, generic drug manufacturers, government, CMOs, biotech, pharma and bioequivalence testing services.